Literature DB >> 12692054

Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders.

S Engler1, C Elsing, C Flechtenmacher, L Theilmann, W Stremmel, A Stiehl.   

Abstract

BACKGROUND: We present nine patients with progressive sclerosing cholangitis after septic shock. PATIENTS: All nine patients had previously required long term treatment in an intensive care unit for septic shock: two patients with polytrauma, five with burn injury, and two with extensive surgery. They were admitted to our hospital because of cholangitis. Endoscopic retrograde cholangiography revealed severe intrahepatic stenoses in all patients and liver biopsies showed typical signs of sclerosing cholangitis. No patient had pre-existing liver disease.
RESULTS: Mean follow up time was 35 months. In patients with major bile duct stenoses (3/9), 12 endoscopic dilations were performed in total. In one patient, concrements were extracted and intermittent stenting was necessary. To date, 4/9 patients have rapidly developed liver cirrhosis. During follow up, 5/9 patients died: two after fulminant cholangitis, one after liver failure, one due to liver transplantation associated problems, and one after cerebral ischaemia. One patient has been registered for transplantation and the remaining three patients show no acute signs of liver failure.
CONCLUSIONS: Patients with sclerosing cholangitis, following septic shock, represent a new variant of vanishing bile duct disorders. In such patients liver disease rapidly progresses to cirrhosis. Endoscopic treatment may only transiently improve the course of the disease. Orthotopic liver transplantation is indicated in end stage disease.

Entities:  

Mesh:

Year:  2003        PMID: 12692054      PMCID: PMC1773636          DOI: 10.1136/gut.52.5.688

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

Review 1.  Cholestatic diseases of liver transplantation.

Authors:  M A Heneghan; P B Sylvestre
Journal:  Semin Gastrointest Dis       Date:  2001-04

Review 2.  The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure.

Authors:  E A Deitch
Journal:  Arch Surg       Date:  1990-03

3.  Histopathology of vanishing bile duct diseases.

Authors: 
Journal:  Adv Clin Path       Date:  1998-04

4.  Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?

Authors:  B Messing; C Bories; F Kunstlinger; J J Bernier
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

5.  Hepatic blood flow and oxygen consumption after burn and sepsis.

Authors:  T Tadros; D L Traber; D N Herndon
Journal:  J Trauma       Date:  2000-07

6.  Endoscopic management of biliary tract strictures in primary sclerosing cholangitis.

Authors:  S Wagner; M Gebel; P Meier; C Trautwein; J Bleck; B Nashan; M P Manns
Journal:  Endoscopy       Date:  1996-09       Impact factor: 10.093

Review 7.  Hepatic complications of total parenteral nutrition.

Authors:  A L Baker; I H Rosenberg
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

8.  Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.

Authors:  Adolf Stiehl; Gerda Rudolph; Petra Klöters-Plachky; Peter Sauer; Siegfried Walker
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

Review 9.  [Secondary sclerosing cholangitis].

Authors:  A Amor; C Chapoutot; J Michel; G P Pageaux; D Larrey; H Michel
Journal:  Presse Med       Date:  1995-06-03       Impact factor: 1.228

10.  [Histological changes in liver tissue in cholestasis].

Authors:  G Machnik
Journal:  Z Gastroenterol       Date:  1993-02       Impact factor: 2.000

View more
  24 in total

1.  Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.

Authors:  Irene Esposito; Andrea Kubisova; Adolf Stiehl; Hasan Kulaksiz; Peter Schirmacher
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

2.  Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience.

Authors:  Ting Lin; Kai Qu; Xinsen Xu; Min Tian; Jie Gao; Chun Zhang; Ying Di; Yuelang Zhang; Chang Liu
Journal:  Front Med       Date:  2014-01-10       Impact factor: 4.592

3.  Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.

Authors:  Johannes Benninger; Rainer Grobholz; Yurdaguel Oeztuerk; Christoph H Antoni; Eckhart G Hahn; Manfred V Singer; Richard Strauss
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 4.  [Acute liver failure. How much diagnostic work-up and therapy does my patient need?].

Authors:  J Hadem; A S Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

5.  Secondary sclerosing cholangitis in a critically ill patient.

Authors:  Krista E Weiss; Juergen K Willmann; R Brooke Jeffrey; Terry S Desser
Journal:  Quant Imaging Med Surg       Date:  2016-04

6.  [Long-term liver damage due to trauma].

Authors:  A Winter; J W Oestmann; S Lenz
Journal:  Chirurg       Date:  2009-10       Impact factor: 0.955

Review 7.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

Review 8.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

9.  Treatment of primary sclerosing cholangitis.

Authors:  Daniel Rost; Hasan Kulaksiz; Adolf Stiehl
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

10.  Liver transplantation for sclerosing cholangitis in a polytraumatized patient.

Authors:  Andreas A Schnitzbauer; Tung-Yu Tsui; Gabriele Kirchner; Marcus N Scherer; Thomas Bein; Hans J Schlitt; Aiman Obed
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.